ARCHIVES

NCI Evaluating PDQ Evaluation

This article is from The Cancer Letter archive.

Vol. 15 No. 35 | September 1, 1989

Download PDF Visit The Full Archive

Related Articles

In Brief: Healy To Use 1 Percent Transfer Authority For TB Research; Zoon Heads FDA’s CBER

March 20, 1992

Vanderbilt Recruits Sosman To Lead Tumor Immunology.

January 18, 2002

Workshop concludes HPV Vaccines Would Be Valuable, Feasible

April 8, 1988

Rep. Wyden Questions NCI Motive For Choosing Not To Pursue RU 486

September 4, 1992

Letters: Kopans To Broder: Response Ignores Major Questions

October 15, 1993

House Committee Seeks Review Of Indirect Costs Of NIH Grantees

July 25, 2013